(Q33774512)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

title

Interleukin-2 alters distribution of CD144 (VE-cadherin) in endothelial cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jason M Schenkel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

7

Howard L Kaufman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

5

Carl Ruby

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Dae Won Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Joseph Broucek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Georges Samaha

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

6 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

Journal of Translational Medicine

19 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

Sensing and alarm function of resident memory CD8⁺ T cells

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062649

Resveratrol prevents endothelial cells injury in high-dose interleukin-2 therapy against melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062649

Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062649

Cytokine-based therapy and biochemotherapy for advanced melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062649

Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4062649

Control of endothelial barrier function by regulating vascular endothelial-cadherin

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1479-5876-12-113

Doxycycline induces membrane expression of VE-cadherin on endothelial cells and prevents vascular hyperpermeability

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1479-5876-12-113

Interleukin-2 and cancer: critical analysis of results, problems and expectations

21 January 2018

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome

1 reference

12 December 2020

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

12 December 2020

Identifiers

DOI

10.1186/1479-5876-12-113

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 March 2020

1 reference

https://scigraph.springernature.com/pub.10.1186/1479-5876-12-113

9 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

PubMed publication ID

24885155

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24885155%20AND%20SRC:MED&resulttype=core&format=json